Value of Hospice Benefit to Medicaid Programs

Size: px
Start display at page:

Download "Value of Hospice Benefit to Medicaid Programs"

Transcription

1 One Pennsylvania Plaza, 38 th Floor New York, NY Tel Fax Value of Hospice Benefit May 2, 2003 Milliman USA, Inc. New York, NY Kate Fitch, RN, MEd, MA Bruce Pyenson, FSA, MAAA Commissioned by the National Hospice and Palliative Care Organization

2 Table of Contents I. Executive Summary...1 II. Limitations IV. Methodology and Findings VII. Appendix A: Background NHPCO and Milliman...8 VIII. Appendix B: Demographics Hospital Discharge Data...9 IX. Appendix C: Demographics Drug Cost Data...10

3 Executive Summary The National Hospice and Palliative Care Organization (NHPCO) retained Milliman USA, Inc. (Milliman) to examine the value of hospice for Medicaid programs. Hospice care seeks to enhance the quality of end of life care for terminally ill patients whose disease is not responsive to curative treatment. Almost all states have chosen to provide hospice benefits to Medicaid recipients. However, federal rules do not require states to provide hospice benefits. The view of Medicaid as covering mostly mothers and children does not lend itself to thinking about hospice benefits. There are, of course, deaths among that young population, but Medicaid also covers populations with much higher mortality, including those suffering from HIV and the poor elderly. NHPCO reports that Medicaid recipients make up about 5% of hospice patients, and additional hospice patients receive both Medicaid and Medicare. In 2001, hospices admitted approximately 775,000 patients; about 40,000 of these had Medicaid as their primary coverage. Many more Medicaid recipients could benefit from hospice care. Our analysis of hospital discharge data suggests that approximately 64,000 Medicaid beneficiaries die annually in hospitals and about 45,000 of these suffered from typical hospice diagnoses. Certainly, other Medicaid beneficiaries that will die out of the hospital could also potentially benefit from hospice. Using the methodology and conservative assumptions described in the body of this report, we estimate that, in 2003, if all states discontinued hospice coverage, national Medicaid spending would increase by about $282 million or approximately $7,000 per beneficiary that would have enrolled in hospice. The increased spending comes from the following components: $228 million: Without hospice, more patients would continue to receive end of life care in a hospital. $41 million: Without hospice, Medicaid would continue to pay for expensive pharmaceutical treatments. $13 million: Without hospice, states will pay about 5% more per day for hospice eligible Medicaid patients in nursing homes, due to technicalities in federal rules. The third component category applies to patients with both Medicaid-only coverage (Medicaid patients without Medicare coverage) and dual coverage (Medicare and Medicaid) while the first two components apply to Medicaid-only patients. Other published and unpublished studies suggest that hospice care reduces costs. The authors of this study have a somewhat different focus -- we demonstrate how removing hospice benefits can increase costs for Medicaid patients. Limitations The conclusions in this report are based on the assumptions and methodology stated in the

4 Value of Hospice Benefit 2 April 25, 2003 body of the report. The reader should not make decisions based on this Executive Summary alone. While key elements of our analysis came from relatively large and credible datasets, variations may well exist that are not reflected in our results. In particular, little data exist on mortality and end-of-life costs for Medicaid populations, so some of our assumptions were formed by data from commercial and Medicare populations. We present national average figures. States and locales have circumstances that will affect the applicability of our results. Local reimbursement levels and the existence of managed care programs are especially important. These and other factors should be used in applying our findings to particular states or locales. Hospice selection bias has become a significant controversy in hospice studies. The question, Are most hospice patients the kind of people who would refuse aggressive end of life care even if there were no hospice benefit? raises the bias issue. The authors have performed studies that suggest cost savings for hospice despite potential bias. However, the bias issue has not been resolved generally, and our results would overstate cost increases if such bias is significant in the Medicaid population. We believe our estimates for cost increases due to ending hospice benefits are based on relatively conservative assumptions; cost increases could well be higher. However, technology changes, reimbursement changes, and other circumstances could occur to reverse such increases or make them very difficult to observe. Variability is inherent in any economic forecast, and that applies to our work here. In performing this study, Milliman USA, Inc. does not intend to take a position on any particular legislation. If this report is copied, it must be distributed in its entirety. The conclusions of this report are based on the authors analysis and should not be interpreted as representing the position of Milliman USA, Inc. We hope the analysis presented here will be useful to all concerned parties. Methodology and Findings Several studies have identified cost savings for Medicare beneficiaries utilizing hospice services compared to similarly matched beneficiaries not utilizing hospice services. 1, 2 The cost savings is in large part, driven by hospice programs focus on maintaining and supporting terminally ill individuals at home, avoiding some hospital stays. In particular, hospice care can help patients avoid dying in a hospital (terminal hospital stays) and ambulatory sensitive hospital stays. In addition to avoiding unnecessary and undesirable hospital utilization, hospice reduces spending because the hospice provides for all medications related to the terminal illness as well as durable medical equipment (DME), medical supplies and home care visits. 1 Mor V, Greer D, Kastenbaum R. The hospice experiment. Baltimore: Johns Hopkins University Press. 2 National Hospice Organization. An analysis of the cost savings of the Medicare Hospice Benefit. (Item No ). Alexandria, VA: Author.

5 Value of Hospice Benefit 3 April 25, 2003 Medicaid-Only Hospice Population The Medicaid-only hospice population for which we modeled our results was identified using NHPCO Facts and Figures data, Hospice Cost Report Summary through 10/31/02, and Hospice Standard Analytic Files 100% Final Action Claims illustrated in Table I. Hospice admissions, in recent years, have grown 10% annually. About 13% of the individuals who begin hospice care discontinue it. We used these considerations to estimate that about 40,000 Medicaid-only recipients will die with hospice care in Table I Projected Medicaid-Only Hospice Recipients Deaths in USA (1) 2,400,000 Hospice Admissions in 2001 (1) 775,000 Hospice Admission Growth Rate Annually (1) 10% Other than Death Discharge Rate Annually (1) 13% Hospice Deaths 815,843 cent of Medicaid-only Hospice Patients (1) (2) 4.9% Medicaid-only Hospice Deaths 40,000 (1) NHPCO Facts and Figures (Updated January 2003) (2) Hospice Cost Report Summary through 10/31/02 Medicaid-Only Cost Savings Avoided Hospitalizations for Terminal Care Hospice programs seek to provide the resources and management to support death at home for terminally ill individuals thereby avoiding terminal hospitalizations dying in a hospital. NHPCO reports 10% of patients who died under hospice care in 2001 died in a hospital. 3 This contrasts to much higher figures for non-hospice patients. Statistics reporting the percent of Medicaid deaths that occur in an acute care hospital have not been available to date. Wennberg reports in The Dartmouth Atlas of Health Care 1999, that 33% of Medicare deaths occur in an acute care hospital. 4 NHPCO reports that for all Americans that died in 2001, less than 50% died in an acute care hospital. 5 According to 3 NHPCO Facts and Figures (Updated January 2003) 4 Wennberg J, The Quality of Medical Care in the United States: A Report on the Medicare Program The Dartmouth Atlas of Health Care 1999, AHA Press, 1999 The Trustees of Dartmouth College 5 NHPCO Facts and Figures (Updated January 2003)

6 Value of Hospice Benefit 4 April 25, 2003 McCallum, 85% of pediatric patients with life limiting conditions die in an acute care hospital. 6 Our analysis of Medicaid hospital deaths shows that 10% of deaths are among the pediatric or young adult population, and an unusually high portion of Medicaid hospital deaths (about 70%) are for conditions that would benefit from hospice care. For our model of ending Medicaid hospice benefits, we assume that, without hospice benefits, 40% of beneficiaries that would have had hospice, die in an acute care hospital. To estimate the cost of a terminal hospitalization, we obtained 2001 hospital discharge data from the hospital discharge databases of 19 states and identified all Medicaid-only beneficiaries who died during a hospital stay (about 38,000 beneficiaries). The demographics for this sample appear in Appendix B. We identified hospice eligible beneficiaries by selecting patients with ICD-9 codes for terminal illness often associated with hospice care. These illnesses included cancer, congestive heart failure, chronic obstructive pulmonary disease, end stage renal and liver disease, HIV and congenital anomalies. We identified about 70% of Medicaid beneficiaries, who died during a hospital stay, to be hospice eligible. Medicaid programs vary greatly in how they reimburse hospitals. We chose to apply a perdiem rate to an average length of stay (LOS) to estimate the average cost of a terminal hospitalization. Medicaid programs generally reimburse hospitals at a much lower level than do commercial insurers or HMOs. We assumed a per-diem reimbursement of $900, which reflects a 40% discount off typical HMO medical-surgical per diems. 7 In the hospital discharge database described above, the mean LOS of a hospice-eligible Medicaid terminal hospitalization was 30 days. Because the mean LOS reflects the impact of very long LOS cases, we chose to use the 70 th percentile of cases - 15 days - as the LOS for a patient who would have received a hospice benefit, but instead died in a hospital. Medicaid programs spending on hospitalization for terminal illness would increase if hospice eligible patients were not able to elect hospice benefits. We used the projected 40,000 Medicaid-only hospice deaths for 2003 to model the impact of the hospice program on shifting beneficiaries from dying in the hospital to dying in the home. We assumed 10% of those receiving hospice would die in the hospital and 40% of those without hospice would die in the hospital. We added a $100 per day cost of hospice care using an average 48-day hospice enrollment. 8 The extra cost to Medicaid without a hospice benefit is $228,000,000 or $5,700 extra cost per Medicaid-only hospice patient. Table II displays the components of these additional costs. In our model, we considered that, without hospice care, patients dying at home will receive home care. We applied a $150 / day cost for home care, which would cover daily home health aide care, several nursing visits per week, DME and medical supplies. To the extent 6 McCallum DE, Byrne P, Bruera E. How children die in hospital. J Pain Symptom Manage. 2000; 20(6): Milliman USA, 2002 HMO Intercompany Survey 8 NHPCO Facts and Figures (Updated January 2003)

7 Value of Hospice Benefit 5 April 25, 2003 that a Medicaid program provides generous home care benefits, this extra cost could be understated. We did not attribute this extra cost for the days of terminal hospitalization. Table II: Extra Terminal Hospitalization Costs, Medicaid-Only Patients 2003 Hospice Benefit Hospice Benefit Not Offered Dying in Hospital Dying at Home Dying in Hospital Dying at Home Medicaid Only Hospice Patients 40,000 40,000 % of Patients who Die in Hospital 10% 40% Patients who Die in Hospital 4,000 16, Estimate Hospital Cost Day (1) $900 $900 Average Terminal LOS (days) Average Terminal Hospital Cost $13,500 $54,000,000 $13,500 $216,000,000 % of Patients receiving Hospice/Home Care 10% Hospice Care 90% Hospice Care 40% Home Care 60% Home Care Patients receiving Hospice/Home Care 4,000 36,000 16,000 24,000 Hospice/Home Care Cost Day $100 $100 $150 $150 Average Hospice/Home Care Days Hospice/Home Care Cost $3,300 $13,000,000 $4,800 $173,000,000 $4,950 $79,000,000 $7,200 $173,000,000 Estimated Terminal Hospitalization Cost $67,000,000 $173,000,000 $195,000,000 $173,000,000 Total Cost by Benefit $240,000,000 $468,000,000 Extra Cost to Medicaid without Hospice Benefit $228,000,000 Extra Cost Medicaid Hospice Eligible Patient without Hospice Benefit $5,700 (1) Estimated from Milliman HCG/Intercompany Rates Survey, 2002

8 Value of Hospice Benefit 6 April 25, 2003 Increased Drug Costs Hospice provides all medications related to the terminal illness. Consequently, we believe that, without hospice, Medicaid s drug costs would increase for people otherwise on hospice. To model the impact of avoided drug costs for Medicaid-only beneficiaries enrolled in hospice, we used a large, commercial insurer database with 2001 claims for about 2 million commercial lives. We identified all individuals that died and had hospice eligible ICD-9 codes for terminal illness (almost 1,000 individuals). The demographics for this sample appear in Appendix C. We identified all prescription drug claims for these individuals including oral, injectables and parenteral drugs. After accounting for a 15% annual drug trend and a 20% price discount received by Medicaid programs, we estimate that, for 2003, prescription drug costs average over $20 per day during each of the last three months of a terminally ill patient s life. In our model, we did not apply this cost during patient s terminal hospitalization, because medication costs would be the hospital s responsibility. Prescriptions are typically dispensed in multi-day amounts, not daily doses. However, applying averages represents a reasonable approach to modeling these costs because the source data also reflected typical prescribing patterns. We estimate the avoided drug costs for the 40,000 Medicaid-only hospice deaths for 2003 to be about $41 million or $1,032 per Medicaid-only hospice patient. Table III illustrates these avoided costs. Table III: Avoided Drug Costs, Medicaid-Only Patients 2003 Hospice Benefit Not Offered Hospice Benefit Dying in Hospital Dying at Home Medicaid-Only Hospice Patients 40,000 40,000 40,000 % of Patients receiving Hospice/Home Care 40% 60% Number of Patients by Site of Death w/o Hospice 16,000 24,000 Diem Allowed Drug Charges $24.99 $24.38 Average Hospice/ Home Care LOS (days) Estimated Drug Cost for these Patients $0 $825 $13,200,000 $1,170 $28,080,000 Additional Drug Cost without Hospice Benefit $41,280,000 Additional Drug Cost Medicaid-Only Hospice Eligible Patient without Hospice Benefit $1,032

9 Value of Hospice Benefit 7 April 25, 2003 Medicaid Nursing Facility Savings According to federal rules, when a Medicaid-only or dually eligible Nursing Facility beneficiary with a Medicaid hospice benefit enrolls in hospice, Medicaid pays hospice 95% of room and board allowable rather than the 100% Medicaid typically pays directly to the Nursing Facility. Hospice in turn reimburses the Nursing Facility 95% percent of room and board. For Nursing Facility hospice eligibles without a Medicaid hospice benefit, Medicaid would pay 100% of the room and board charges to the Nursing Facility. Based on the hospice cost report, we estimate that the national total room and board revenue paid for Medicaid beneficiaries receiving hospice care in Nursing Facilities is about $255 million in We estimate that, without the hospice benefit, Medicaid spending would increase by about $13 million. Table IV illustrates these additional costs to Medicaid without the hospice benefit for Medicaid Nursing Facility beneficiaries. Table IV: Medicaid Nursing Facility (NF) 5% Room and Board Discount Hospice Benefit 2001 Medicare Hospice Payments (1) $3,610,700,000 Medicare Payments as a % of Total Hospice Revenue (2) 85% Hospice Benefit Not Offered 2001 Total Hospice Revenue $4,248,000,000 Medicaid Room & Board Revenue (2) $251,455,473 Total Patient Revenue (2) $4,182,420,069 Medicaid NF Payments as a % of Hospice Revenue (2) 6% Medicaid NF Hospice Payments (payments with 5% room and board discount) $254,880,000 (payments without 5% room and board discount) $268,295,000 Estimated Medicaid NF Cost $254,880,000 $268,287,307 Additional NF Room & Board Cost without Hospice Benefit $13,415,000 (1) Standard Analytic Files - 100% Final Action Claims (2) Hospice Cost Report Summary through 10/31/02

10 Value of Hospice Benefit 8 April 25, 2003 Appendix A The National Hospice and Palliative Care Organization The National Hospice and Palliative Care Organization (NHPCO) is the largest nonprofit membership organization representing hospice and palliative care programs and professionals in the United States. Founded in 1978, the organization is committed to improving end of life care and expanding access to hospice care with the goal of profoundly enhancing quality of life for people dying in America and their loved ones. Hospice care seeks to enhance the quality of end of life care for terminally ill patients whose disease is not responsive to curative treatment. Hospice care involves a team-oriented approach of expert medical care, pain management, and emotional and spiritual support expressly tailored to the patient s needs and wishes. Emotional and spiritual support is extended to the family as well. Generally this care is provided in the patient s home or in a home-like setting operated by a hospice program. In most states, Medicare, Medicaid and private health insurance cover hospice care for patients who meet certain criteria. As of 2001, there were approximately 3,200 operational or planned hospice programs located in the 50 states, the District of Columbia, Puerto Rico and Guam. NHPCO s membership includes over 2,000 hospice programs. NHPCO estimates that 775,000 patients were served by hospices in the U.S. in Milliman USA, Inc. Milliman is an international firm of consultants and actuaries. With over 2,000 employees, Milliman uses actuarial and clinical expertise to provide consulting services to a full range of financial and health care organizations, providers, governments and employers. The authors of this report are located in Milliman s New York City office. The authors of this study are Kate Fitch, RN, MEd, MA, and Bruce Pyenson, FSA, MAAA. They have collaborated on other hospice projects, including a report on how the components of hospice costs have changed since the beginning of the Medicare hospice benefit 9. The authors backgrounds are described below. Kate Fitch is a Healthcare Management Consultant in Milliman s New York City office. Kate s background includes catastrophic disease management operations, utilization management training for hospitals and HMOs and nursing education and research. She has been with Milliman since Bruce Pyenson is a Principal and Consulting Actuary in Milliman s New York City office. Bruce has led projects relating to healthcare reform, such as Mental Health Parity, and has consulted to healthcare providers, HMOs and pharmaceutical companies on various risk management issues. He has been with Milliman since The Costs of Hospice Care, National Hospice and Palliative Care Organization, 2001.

11 Value of Hospice Benefit 9 April 25, 2003 Appendix B Distribution of Inpatient Medicaid Deaths by Age and Sex Age Category Female Male 0 to 1 years 2.8% 3.2% 2 to 6 years 0.4% 0.4% 7 to 18 years 0.8% 0.9% 19 to 24 years 0.6% 0.7% 25 to 29 years 0.9% 0.9% 30 to 34 years 2.3% 2.7% 35 to 39 years 2.4% 2.7% 40 to 44 years 3.4% 4.5% 45 to 49 years 4.2% 5.9% 50 to 54 years 4.8% 6.0% 55 to 59 years 6.6% 7.2% 60 to 64 years 6.8% 6.7% 65 to 69 years 2.3% 1.9% 70 to 74 years 2.3% 2.0% 75 to 79 years 2.3% 1.8% 80 to 84 years 2.2% 1.6% 85 and older 4.0% 1.9% Note: The above age-sex distribution of deaths is based on about 38,000 hospital discharges in 2001 from 19 states. For some states, ages were presented as bands or sex unidentified. For such cases, we used a simple allocation to create the above table. While we believe these data are predominantly Medicaid-only patients, the coding practices of hospitals and states varies, and we urge the reader to use caution in interpreting the above data.

12 Value of Hospice Benefit 10 April 25, 2003 Appendix C Distribution of Hospice Eligibles with Prescription Drug Claims by Age and Sex Age Category Female Male 0 to 1 years 0.2% 0.4% 2 to 6 years 0.1% 0.2% 7 to 18 years 0.4% 0.1% 19 to 24 years 0.0% 0.4% 25 to 29 years 0.5% 0.6% 30 to 34 years 1.0% 1.4% 35 to 39 years 1.7% 1.1% 40 to 44 years 3.1% 2.6% 45 to 49 years 4.7% 5.0% 50 to 54 years 4.8% 6.2% 55 to 59 years 5.7% 10.4% 60 to 64 years 8.2% 11.2% 65 to 69 years 1.9% 4.6% 70 to 74 years 1.2% 2.7% 75 to 79 years 2.1% 4.6% 80 to 84 years 1.9% 3.5% 85 and older 4.1% 3.5% Note: The above age-sex distribution of patients with drug claims is based on over 1 million commercial lives in 2001 excluding hospice patients. While we believe the data represents a predominantly hospice eligible population, the coding practices of hospitals and states varies, and we urge the reader to use caution in interpreting the above data.

SENATE AND ASSEMBLY HEARING ON THE EXECUTIVE HEALTH BUDGET PROPOSAL

SENATE AND ASSEMBLY HEARING ON THE EXECUTIVE HEALTH BUDGET PROPOSAL 2017-2018 SENATE AND ASSEMBLY HEARING ON THE EXECUTIVE HEALTH BUDGET PROPOSAL February 16, 2017 Testimony from the Hospice and Palliative Care Association of New York State Introduction The Hospice and

More information

REPORT OF THE COUNCIL ON MEDICAL SERVICE

REPORT OF THE COUNCIL ON MEDICAL SERVICE REPORT OF THE COUNCIL ON MEDICAL SERVICE CMS Report -I- Subject: Presented by: Referred to: Concurrent Hospice and Curative Care (Resolution 0-I-) Peter S. Lund, MD, Chair Reference Committee J (Candace

More information

There For You. Your Compassionate Guide. World-Class Hospice Care Since 1979

There For You. Your Compassionate Guide. World-Class Hospice Care Since 1979 There For You Your Compassionate Guide World-Class Hospice Care Since 1979 What Is Hospice? Hospice is a type of care designed to provide support during an advanced illness. Hospice care focuses on comfort

More information

The Cost Burden of Worsening Heart Failure in the Medicare Fee For Service Population: An Actuarial Analysis

The Cost Burden of Worsening Heart Failure in the Medicare Fee For Service Population: An Actuarial Analysis Client Report Milliman Client Report The Cost Burden of Worsening Heart Failure in the Medicare Fee For Service Population: An Actuarial Analysis Prepared by Kathryn Fitch, RN, MEd Principal and Healthcare

More information

Palliative Care and Hospice. University of Illinois at Chicago College of Nursing

Palliative Care and Hospice. University of Illinois at Chicago College of Nursing Palliative Care and Hospice University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this module, participants will be better able to: 1. Describe Palliative Care 2.

More information

Cost-Motivated Treatment Changes in Commercial Claims:

Cost-Motivated Treatment Changes in Commercial Claims: Cost-Motivated Treatment Changes in Commercial Claims: Implications for Non- Medical Switching August 2017 THE MORAN COMPANY 1 Cost-Motivated Treatment Changes in Commercial Claims: Implications for Non-Medical

More information

Hospice and Palliative Care An Essential Component of the Aging Services Network

Hospice and Palliative Care An Essential Component of the Aging Services Network Hospice and Palliative Care An Essential Component of the Aging Services Network Howard Tuch, MD, MS American Academy of Hospice and Palliative Medicine Physician Advocate, American Academy of Hospice

More information

Chapter 6: Healthcare Expenditures for Persons with CKD

Chapter 6: Healthcare Expenditures for Persons with CKD Chapter 6: Healthcare Expenditures for Persons with CKD In this 2017 Annual Data Report (ADR), we introduce information from the Optum Clinformatics DataMart for persons with Medicare Advantage and commercial

More information

Medicare Severity-adjusted Diagnosis Related Groups (MS-DRGs) Coding Adjustment

Medicare Severity-adjusted Diagnosis Related Groups (MS-DRGs) Coding Adjustment American Hospital association December 2012 TrendWatch Are Medicare Patients Getting Sicker? Today, Medicare covers more than 48 million people, and that number is growing rapidly baby boomers are reaching

More information

By Crossroads Hospice UNDERSTANDING COMORBIDITIES AND TREATMENT OPTIONS IN HOSPICE CARE

By Crossroads Hospice UNDERSTANDING COMORBIDITIES AND TREATMENT OPTIONS IN HOSPICE CARE By Crossroads Hospice UNDERSTANDING COMORBIDITIES AND TREATMENT OPTIONS IN HOSPICE CARE UNDERSTANDING COMORBIDITIES AND TREATMENT OPTIONS IN HOSPICE CARE No two hospice patients are the same. This statement

More information

UNDERSTANDING COMORBIDITIES AND TREATMENT OPTIONS IN HOSPICE CARE

UNDERSTANDING COMORBIDITIES AND TREATMENT OPTIONS IN HOSPICE CARE UNDERSTANDING COMORBIDITIES AND TREATMENT OPTIONS IN HOSPICE CARE By Crossroads Hospice & Palliative Care UNDERSTANDING COMORBIDITIES AND TREATMENT OPTIONS IN HOSPICE CARE No two hospice patients are the

More information

Trends in Hospice Utilization

Trends in Hospice Utilization Proposed FY 2017 Hospice Wage Index and Rate Update and Hospice Quality Reporting Requirements To: NHPCO Provider Members From: Health Policy Team Date: April 25, 2016 On April 21, 2016, the Centers for

More information

Death and Dying in California

Death and Dying in California s n a p s h o t in California 2006 Introduction In the past 100 years, the way we die and the way we deal with death has changed radically. As medicines that combat bacterial and viral infections allow

More information

There Is Something More We Can Do: An Introduction to Hospice and Palliative Care

There Is Something More We Can Do: An Introduction to Hospice and Palliative Care There Is Something More We Can Do: An Introduction to Hospice and Palliative Care presented to the Washington Patient Safety Coalition July 28, 2010 Hope Wechkin, MD Medical Director Evergreen Hospice

More information

Mapping Palliative Care Need and Supply in California: Methodology

Mapping Palliative Care Need and Supply in California: Methodology Mapping Palliative Care Need and Supply in California: Methodology February 2015 Kathleen Kerr, Kerr Healthcare Analytics Mike Rabow, MD, University of California San Francisco J. Brian Cassel, PhD, Virginia

More information

Performance Analysis:

Performance Analysis: Performance Analysis: Healthcare Utilization of CCNC- Population 2007-2010 Prepared by Treo Solutions JUNE 2012 Table of Contents SECTION ONE: EXECUTIVE SUMMARY 4-5 SECTION TWO: REPORT DETAILS 6 Inpatient

More information

Hospice Care in Wyoming. Robert Monger, M.D., F.A.C.P Frontiers in Wyoming Medicine Conference February 6 th, 2014

Hospice Care in Wyoming. Robert Monger, M.D., F.A.C.P Frontiers in Wyoming Medicine Conference February 6 th, 2014 Hospice Care in Wyoming Robert Monger, M.D., F.A.C.P. 2014 Frontiers in Wyoming Medicine Conference February 6 th, 2014 What is Hospice? Compassionate care for people facing a life-limiting illness or

More information

Statement Of. The National Association of Chain Drug Stores. For. U.S. Senate Committee on Finance. Hearing on:

Statement Of. The National Association of Chain Drug Stores. For. U.S. Senate Committee on Finance. Hearing on: Statement Of The National Association of Chain Drug Stores For U.S. Senate Committee on Finance Hearing on: 10:00 a.m. National Association of Chain Drug Stores (NACDS) 1776 Wilson Blvd., Suite 200 Arlington,

More information

Chapter 6. Hospice: A Team Approach to Care

Chapter 6. Hospice: A Team Approach to Care Chapter 6 Hospice: A Team Approach to Care Chapter 6: Hospice: A Team Approach to Care Comfort, Respect and Dignity in Dying Hospice care provides patients and family members with hope, comfort, respect,

More information

Statement Of. The National Association of Chain Drug Stores. For. U.S. House of Representatives Committee on the Budget.

Statement Of. The National Association of Chain Drug Stores. For. U.S. House of Representatives Committee on the Budget. Statement Of The National Association of Chain Drug Stores For U.S. House of Representatives Committee on the Budget Hearing on: 2:00 p.m. 210 Cannon House Office Building National Association of Chain

More information

Advancing the management of Chronic Kidney Disease. Employee Benefits Planning Association- December s Program 12/6/2017 1

Advancing the management of Chronic Kidney Disease. Employee Benefits Planning Association- December s Program 12/6/2017 1 Advancing the management of Chronic Kidney Disease. Employee Benefits Planning Association- December s Program 12/6/2017 1 Today s Topics Chronic Kidney Disease Causes & Financial Impact Managing comorbid

More information

POSITION STATEMENT ON HEALTH CARE REFORM NADP PRINCIPLES FOR EXPANDING ACCESS TO DENTAL HEALTH BENEFITS

POSITION STATEMENT ON HEALTH CARE REFORM NADP PRINCIPLES FOR EXPANDING ACCESS TO DENTAL HEALTH BENEFITS POSITION STATEMENT ON HEALTH CARE REFORM THE NATIONAL ASSOCIATION OF DENTAL PLANS (NADP) is the nation s largest association of companies providing dental benefits. NADP members cover 136 million Americans

More information

UPDATE 127. The Medicare Hospice Benefit: Unanticipated Cost And Access Impacts?

UPDATE 127. The Medicare Hospice Benefit: Unanticipated Cost And Access Impacts? UPDATE 127 The Medicare Hospice Benefit: Unanticipated Cost And Access Impacts? As a result of passage of P.L. 97-248, the Tax Equity and Fiscal Responsibility Act of 1982 (TEFRA), a hospice benefit under

More information

Drug Overdose Morbidity and Mortality in Kentucky,

Drug Overdose Morbidity and Mortality in Kentucky, Drug Overdose Morbidity and Mortality in Kentucky, 2000-2010 An examination of statewide data, including the rising impact of prescription drug overdose on fatality rates, and the parallel rise in associated

More information

C-Change Making the Business Case Questions & Answers

C-Change Making the Business Case Questions & Answers C-Change Making the Business Case Questions & Answers How To Use This Document Following are a set of questions and answers about C-Change s multi-year Making the Business Case for cancer prevention and

More information

Health Care Reform and Hepatitis C: A Convergence of Risk and Opportunity

Health Care Reform and Hepatitis C: A Convergence of Risk and Opportunity Health Care Reform and Hepatitis C: A Convergence of Risk and Opportunity Prepared by Milliman, Inc., NY Kathryn Fitch, RN, MEd Principal and Healthcare Management Consultant Kosuke Iwasaki, FIAJ, MAAA,

More information

Alzheimer s s Disease (AD) Prevalence

Alzheimer s s Disease (AD) Prevalence Barriers to Quality End of Life Care for People with Dementia Steve McConnell, PhD Alzheimer s s Association Washington, DC Office Alliance for Health Care Reform Briefing on End of Life Care June 8, 2007

More information

Approaches to Predictive Modeling for Palliative or Hospice Care Management

Approaches to Predictive Modeling for Palliative or Hospice Care Management Approaches to Predictive Modeling for Palliative or Hospice Care Management Donald L. Libby, PhD and Stephen Saunders, MD Fourth National Predictive Modeling Summit September 15-16, 2010 Presenters Donald

More information

Spending estimates from Cancer Care Spending

Spending estimates from Cancer Care Spending CALIFORNIA HEALTHCARE FOUNDATION August 2015 Estimating Cancer Care Spending in the California Medicare Population: Methodology Detail This paper describes in detail the methods used by Deborah Schrag,

More information

Regulations & Standards for Hospice Managers

Regulations & Standards for Hospice Managers Regulations & Standards for Hospice Managers A Level I Module of the Hospice MDP Objectives Identify the difference between regulations, standards and guidelines Describe and discuss the regulations for

More information

January 16, Dear Administrator Verma:

January 16, Dear Administrator Verma: Ms. Seema Verma Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Attention: CMMI New Direction P.O. Box 8011 Baltimore, MD 21244-1850 Re: (CMS-4182-P) Medicare

More information

Hospice: Life s Final Journey Are You Ready?

Hospice: Life s Final Journey Are You Ready? Hospice: Life s Final Journey Are You Ready? Anthony D Antonio Senior Director, Business Development Sodexo Senior Living Agenda I. Government Scrutiny and Hospice II. III. IV. What is Hospice? NHPCO Facts

More information

Hospice Metrics Using Medicare Data to Measure Access and Performance for Hospice and Palliative Care

Hospice Metrics Using Medicare Data to Measure Access and Performance for Hospice and Palliative Care Hospice Metrics Using Medicare Data to Measure Access and Performance for Hospice and Palliative Care 1 Outline What are the Medicare data? What are the important metrics? Why hospitals matter so much

More information

A Quick Talk About Hospice As a Local Community Resource

A Quick Talk About Hospice As a Local Community Resource A Quick Talk About Hospice As a Local Community Resource 1 Agenda A Very Brief Overview of Hospice Care Your Local Hospice as a Greif & Bereavement Resource 2 David Stone, LCSW, ACSW, CAE Chief Executive

More information

Foundations in Community-Based Palliative Care Essential Elements for Success

Foundations in Community-Based Palliative Care Essential Elements for Success Foundations in Community-Based Palliative Care Essential Elements for Success Presented by Russell K Portenoy MD Foundations in Community-Based Palliative Care Essential Elements for Success Russell K

More information

MYTH BUSTERS. Market Intelligence Reveals New Insights to Old Growth Measures. Excel Health TM. Myth vs. Reality

MYTH BUSTERS. Market Intelligence Reveals New Insights to Old Growth Measures. Excel Health TM. Myth vs. Reality Excel Health TM MYTH BUSTERS Market Intelligence Reveals New Insights to Old Growth Measures By looking deeply into the CMS Chronic Conditions Data Warehouse, Excel Health challenges the hospice industry

More information

Jukti Kumar Kalita, PhD Business Analytics and Insights Pfizer Presented at:

Jukti Kumar Kalita, PhD Business Analytics and Insights Pfizer Presented at: Hospital to Retail Spillover Analysis and Its Impact on Commercial Decision Making Jukti Kumar Kalita, PhD Business Analytics and Insights Pfizer Presented at: 1 Disclaimer The information provided and

More information

Understanding Hierarchical Condition Categories (HCC)

Understanding Hierarchical Condition Categories (HCC) Understanding Hierarchical Condition Categories (HCC) How hierarchical condition category coding will impact your practice and how you can use these codes to increase quality, improve the patient experience,

More information

Health Issues for Aging Populations

Health Issues for Aging Populations This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

2014 U.S. organ and tissue transplant cost estimates and discussion

2014 U.S. organ and tissue transplant cost estimates and discussion Prepared by: T. Scott Bentley, FSA Principal and Consulting Actuary Peer Reviewed By: Steven G. Hanson, ASA Actuary 2014 U.S. organ and tissue transplant cost estimates and discussion Prepared by: T. Scott

More information

How Many Times? Result: an Unsatisfactory Outcome That Can Be Avoided

How Many Times? Result: an Unsatisfactory Outcome That Can Be Avoided Removing Obstacles to a Peaceful Death by Revising Health Professional Training and Payment Systems Professor Kathy L. Cerminara Nova Southeastern University Shepard Broad College of Law October 24, 2018

More information

INDIANA HEALTH COVERAGE PROGRAMS

INDIANA HEALTH COVERAGE PROGRAMS INDIANA HEALTH COVERAGE PROGRAMS PROVIDER CODE TABLES Note: Due to possible changes in Indiana Health Coverage Programs (IHCP) policy or national coding updates, inclusion of a code on the code tables

More information

Heart Attack Readmissions in Virginia

Heart Attack Readmissions in Virginia Heart Attack Readmissions in Virginia Schroeder Center Statistical Brief Research by Mitchell Cole, William & Mary Public Policy, MPP Class of 2017 Highlights: In 2014, almost 11.2 percent of patients

More information

Comparison of Medicare Fee-for-Service Beneficiaries Treated in Ambulatory Surgical Centers and Hospital Outpatient Departments

Comparison of Medicare Fee-for-Service Beneficiaries Treated in Ambulatory Surgical Centers and Hospital Outpatient Departments Comparison of Medicare Fee-for-Service Beneficiaries Treated in Ambulatory Surgical Centers and Hospital Outpatient Departments Prepared for: American Hospital Association April 4, 2019 Berna Demiralp,

More information

Questions and Answers on 2009 H1N1 Vaccine Financing

Questions and Answers on 2009 H1N1 Vaccine Financing Questions and Answers on 2009 H1N1 Vaccine Financing General Financing Questions Considerations of financing distinguish between those related to the vaccine itself, the ancillary supplies needed to administer

More information

MODULE 1 PALLIATIVE NURSING CARE

MODULE 1 PALLIATIVE NURSING CARE Curriculum MODULE 1 PALLIATIVE NURSING CARE Objectives Describe the role of the nurse in providing quality palliative care for patients across the lifespan. Identify the need for collaborating with interdisciplinary

More information

32 CFR (a)(4), (a)(6)(iii), and (a)(6)(iv)

32 CFR (a)(4), (a)(6)(iii), and (a)(6)(iv) CHAPTER 15 SECTION 1 ISSUE DATE: November 6, 2007 AUTHORITY: 32 CFR 199.14(a)(4), (a)(6)(iii), and (a)(6)(iv) I. APPLICABILITY This policy is mandatory for the reimbursement of services provided either

More information

Achieving earlier entry to hospice care: Issues and strategies. Sonia Lee, APN, GCNS-BC

Achieving earlier entry to hospice care: Issues and strategies. Sonia Lee, APN, GCNS-BC Achieving earlier entry to hospice care: Issues and strategies Sonia Lee, APN, GCNS-BC Objectives The learner will: Describe the benefits of hospice List at least barriers to early hospice care List at

More information

Palliative care services and home and community care services inquiry

Palliative care services and home and community care services inquiry 3 August 20120 Mr Peter Dowling MP Chair, Health and Community Services Committee Parliament House George Street Brisbane QLD 4000 Email: hcsc@parliament.qld.gov.au Dear Mr Dowling, Palliative care services

More information

The Third-Party Reimbursement Process for Orthotics

The Third-Party Reimbursement Process for Orthotics The Third-Party Reimbursement Process for Orthotics When the foot hits the ground, everything changes. We know that over 90% of the population suffers with overpronation of their feet. Implementing Foot

More information

APR DRG Data Discovery

APR DRG Data Discovery APR DRG Data Discovery Henry Johnson MD, MPH Midas+ Vice President and Medical Director Vanessa Dorr RN MSN Midas+ DataVision Clinical Consultant Review: Agenda 3M APR DRG Methodology DataVision: Web and

More information

Positive Airway Pressure (PAP) Devices Physician Frequently Asked Questions December 2008

Positive Airway Pressure (PAP) Devices Physician Frequently Asked Questions December 2008 Positive Airway Pressure (PAP) Devices Physician Frequently Asked Questions December 2008 Based on questions received from the clinical community, the following Frequently Asked Questions will address

More information

To Cover or Not To Cover? A Review of Medication Coverage Guidelines. Dr. Sherita D. Castille, Pharm D Clinical Pharmacist. Agenda.

To Cover or Not To Cover? A Review of Medication Coverage Guidelines. Dr. Sherita D. Castille, Pharm D Clinical Pharmacist. Agenda. To Cover or t To Cover? A Review of Medication Coverage Guidelines Dr. Sherita D. Castille, Pharm D Clinical Pharmacist Agenda 2 Overview Define key Medicare terms Determine relatedness to terminal prognosis

More information

REPORT OF THE COUNCIL ON MEDICAL SERVICE

REPORT OF THE COUNCIL ON MEDICAL SERVICE REPORT OF THE COUNCIL ON MEDICAL SERVICE CMS Report -I- Subject: Presented by: Referred to: Hearing Aid Coverage (Resolutions -I- and -I-) Robert E. Hertzka, MD, Chair Reference Committee J (Jeffrey P.

More information

Statement Of. The National Association of Chain Drug Stores. For. U.S. Senate Finance Committee. Hearing on:

Statement Of. The National Association of Chain Drug Stores. For. U.S. Senate Finance Committee. Hearing on: Statement Of The National Association of Chain Drug Stores For U.S. Senate Finance Committee Hearing on: 10:30 a.m. 215 Dirksen Senate Office Building National Association of Chain Drug Stores (NACDS)

More information

Hospital Discharge Data

Hospital Discharge Data Hospital Discharge Data West Virginia Health Care Authority Hospitalization data were obtained from the West Virginia Health Care Authority s (WVHCA) hospital discharge database. Data are submitted by

More information

Billing & Coding Guide

Billing & Coding Guide Billing & Coding Guide CMS established a unique J-code to facilitate reimbursement of ENVARSUS XR J7503 Suggested Coding and Medicare Allowables Coding Overview and Payment Rates Used to Report Code Description

More information

Palliative Care to Hospice: Forging an Effective Partnership. Dennis Cox, LCSW

Palliative Care to Hospice: Forging an Effective Partnership. Dennis Cox, LCSW Palliative Care to Hospice: Forging an Effective Partnership Dennis Cox, LCSW The Old Days Home Care or Hospice There was a clear choice Physicians needed to take a stand Have the Hospice conversation

More information

PHPG. Utilization and Expenditure Analysis for Dually Eligible SoonerCare Members with Chronic Conditions

PHPG. Utilization and Expenditure Analysis for Dually Eligible SoonerCare Members with Chronic Conditions PHPG The Pacific Health Policy Group Utilization and Expenditure Analysis for Dually Eligible SoonerCare Members with Chronic Conditions Prepared for: State of Oklahoma Oklahoma Health Care Authority April

More information

The Opioid Crisis among the Privately Insured

The Opioid Crisis among the Privately Insured The Opioid Crisis among the Privately Insured The Opioid Abuse Epidemic as Documented in Private Claims Data A FAIR Health White Paper, July 2016 Copyright 2016, FAIR Health, Inc. Summary The United States

More information

Include Substance Use Disorder Services in New Hampshire Medicaid Managed Care

Include Substance Use Disorder Services in New Hampshire Medicaid Managed Care Include Substance Use Disorder Services in New Hampshire Medicaid Managed Care New Futures mission is to advocate, educate, and collaborate to reduce alcohol and other drug problems in New Hampshire. Expanding

More information

Module 1: Principles of Palliative Care. Part I: Dying Well. A Good Death Defined

Module 1: Principles of Palliative Care. Part I: Dying Well. A Good Death Defined E L N E C End-of-Life Nursing Education Consortium Geriatric Curriculum Module 1: Principles of Palliative Care Part I: Dying Well A natural part of life Opportunity for growth Profoundly personal experience

More information

Trends in Pneumonia and Influenza Morbidity and Mortality

Trends in Pneumonia and Influenza Morbidity and Mortality Trends in Pneumonia and Influenza Morbidity and Mortality American Lung Association Epidemiology and Statistics Unit Research and Health Education Division November 2015 Page intentionally left blank Introduction

More information

Palliative Care for Older Adults in the United States

Palliative Care for Older Adults in the United States Palliative Care for Older Adults in the United States Nathan Goldstein, MD Associate Professor Hertzberg Palliative Care Institute Brookdale Department of Geriatrics and Palliative Medicine Icahn School

More information

Huangdao People's Hospital

Huangdao People's Hospital Table of contents 1. Background... 3 2. Integrated care pathway implementation... 6 (1) Workload indicators... 6 A. In eligible for care pathway... 6 B. Care pathway implementation... 7 (2) Outcome indicators...

More information

Cost of Mental Health Care

Cost of Mental Health Care Section 4 Cost of Mental Health Care Per capita mental health spending for Americans with a mental health diagnosis has increased among children, peaking in. For adults, the spending has been more stable.

More information

Insurance Guide For Dental Healthcare Professionals

Insurance Guide For Dental Healthcare Professionals Insurance Guide For Dental Healthcare Professionals Dental Benefits Basics What is dental insurance? Unlike traditional insurance, dental benefits are not meant to cover all oral healthcare needs. The

More information

Quality of Life (F309 End of Life) Interpretive Guidance Investigative Protocol

Quality of Life (F309 End of Life) Interpretive Guidance Investigative Protocol 483.25 Quality of Life (F309 End of Life) Interpretive Guidance Investigative Protocol 2 483.25 End of Life Each resident must receive and the facility must provide the necessary care and services to attain

More information

New patients approved for the Novo Nordisk PAP may only be eligible for insulin vials. For a full list of available products, please visit:

New patients approved for the Novo Nordisk PAP may only be eligible for insulin vials. For a full list of available products, please visit: The Novo Nordisk Diabetes Patient Assistance Program (PAP) provides medication to qualifying applicants at no charge. If the applicant qualifies under the Novo Nordisk Diabetes PAP guidelines, a 120-day

More information

The case for daily dialysis: its impact on costs and quality of life Mohr P E, Neumann P J, Franco S J, Marainen J, Lockridge R, Ting G

The case for daily dialysis: its impact on costs and quality of life Mohr P E, Neumann P J, Franco S J, Marainen J, Lockridge R, Ting G The case for daily dialysis: its impact on costs and quality of life Mohr P E, Neumann P J, Franco S J, Marainen J, Lockridge R, Ting G Record Status This is a critical abstract of an economic evaluation

More information

Substance Misuse in New Hampshire: An Update on Costs to the State s Economy and Initial Impacts of Public Policies to Reduce Them

Substance Misuse in New Hampshire: An Update on Costs to the State s Economy and Initial Impacts of Public Policies to Reduce Them Substance Misuse in New Hampshire: An Update on Costs to the State s Economy and Initial Impacts of Public Policies to Reduce Them May 2017 Prepared by: Sponsored by: Table of Contents EXECUTIVE SUMMARY...

More information

The Sustainability of Irish Pharmaceutical Expenditure. Valerie Walshe Ph.D. Economist

The Sustainability of Irish Pharmaceutical Expenditure. Valerie Walshe Ph.D. Economist The Sustainability of Irish Pharmaceutical Expenditure Valerie Walshe Ph.D. Economist valerie.walshe@hse.ie February 2015 Content Overview of Irish Health Services Community Drug Prescribing Trends Driving

More information

Per Capita Health Care Spending on Diabetes:

Per Capita Health Care Spending on Diabetes: Issue Brief #10 May 2015 Per Capita Health Care Spending on Diabetes: 2009-2013 Diabetes is a costly chronic condition in the United States, medical costs and productivity loss attributable to diabetes

More information

Medicare Hospice Benefits

Medicare Hospice Benefits CENTERS for MEDICARE & MEDICAID SERVICES Medicare Hospice Benefits This official government booklet includes information about Medicare hospice benefits: Who s eligible for hospice care What services are

More information

Palliative Care Quality Improvement Program (QIP) Measurement Specifications

Palliative Care Quality Improvement Program (QIP) Measurement Specifications Palliative Care Quality Improvement Program (QIP) 2017-18 Measurement Specifications Developed by: QIP Team Contact: palliativeqip@partnershiphp.org Published on: October 6, 2017 Table of Contents Program

More information

The Changing Landscape of Palliative Care

The Changing Landscape of Palliative Care The Changing Landscape of Palliative Care KAHPC 17th Annual Conference August 2015 Brian Jones Joe Rotella Elizabeth Wessels Turner West Kay Williams Why Home-based Palliative Care? Turner West, MPH, MTS

More information

Ethical Practice Guidelines on Financial Incentives from Hearing Instrument Manufacturers

Ethical Practice Guidelines on Financial Incentives from Hearing Instrument Manufacturers Ethical Practice Guidelines on Financial Incentives from Hearing Instrument Manufacturers Ethical Guidelines The following general guidelines have been accepted by the Board of Directors of the Academy

More information

USRDS UNITED STATES RENAL DATA SYSTEM

USRDS UNITED STATES RENAL DATA SYSTEM USRDS UNITED STATES RENAL DATA SYSTEM Chapter 6: Medicare Expenditures for Persons With CKD Medicare spending for patients with CKD aged 65 and older exceeded $50 billion in 2013, representing 20% of all

More information

August 16, Healthy Living Conference For Seniors and Caregivers VITAS 1. What we Know. Defining Palliative Care: Comfort. Symptom Management.

August 16, Healthy Living Conference For Seniors and Caregivers VITAS 1. What we Know. Defining Palliative Care: Comfort. Symptom Management. Comfort. Symptom Management. Respect. & Hospice Care Pam Wright, LCSW Licensed Clinical Social Worker pamela.wright@vitas.com 626-918-2273 What we Know Defining : Palliative care is medical care that relieves

More information

Massachusetts Medicaid pediatric high-risk asthma bundled payment pilot

Massachusetts Medicaid pediatric high-risk asthma bundled payment pilot University of Massachusetts Medical School escholarship@umms Commonwealth Medicine Publications Commonwealth Medicine 9-28-2011 Massachusetts Medicaid pediatric high-risk asthma bundled payment pilot Katharine

More information

Miami-Dade County Prepaid Dental Health Plan Demonstration: Less Value for State Dollars

Miami-Dade County Prepaid Dental Health Plan Demonstration: Less Value for State Dollars Miami-Dade County Prepaid Dental Health Plan Demonstration: Less Value for State Dollars Analysis commissioned by The Collins Center for Public Policy / Community Voices Miami AUGUST 2006 Author: Burton

More information

Palliative Care & Private Health Insurance

Palliative Care & Private Health Insurance Palliative Care & Private Health Insurance Focus of Presentation 1. Legislation 2. Early Review of Changes 3. Trends in Palliative Care Mandatory Coverage Coverage by Insurers 4. MBS & Palliative Care

More information

Financial Impact of Emergency Department Visits by Adults for Dental Conditions in Maryland

Financial Impact of Emergency Department Visits by Adults for Dental Conditions in Maryland Financial Impact of Emergency Department by Adults for Dental Conditions in Maryland Background Access to dental care remains challenging for many children and adults. Lack of preventive care services

More information

Do OurHealth primary care clinics improve health & reduce healthcare costs? OurHealth Patient Engagement Analysis June 2018

Do OurHealth primary care clinics improve health & reduce healthcare costs? OurHealth Patient Engagement Analysis June 2018 Question: Do OurHealth primary care clinics improve health & reduce healthcare costs? OurHealth Patient Engagement Analysis June 2018 An examination of health improvements, utilization & cost of care for

More information

Founded in 1978 as Hospice of the North Shore. Know Your Choices. A Guide for People with Serious Illness

Founded in 1978 as Hospice of the North Shore. Know Your Choices. A Guide for People with Serious Illness Founded in 1978 as Hospice of the North Shore Know Your Choices A Guide for People with Serious Illness Advance Care Planning: Expressing Your Wishes In Massachusetts, all patients with serious advancing

More information

Quality of Life (F309 End of Life) Surveyor Train the Trainer: Interpretive Guidance Investigative Protocol

Quality of Life (F309 End of Life) Surveyor Train the Trainer: Interpretive Guidance Investigative Protocol 483.25 Quality of Life (F309 End of Life) Surveyor Train the Trainer: Interpretive Guidance Investigative Protocol 2 483.25 End of Life Each resident must receive and the facility must provide the necessary

More information

Appendix C NEWBORN HEARING SCREENING PROJECT

Appendix C NEWBORN HEARING SCREENING PROJECT Appendix C NEWBORN HEARING SCREENING PROJECT I. WEST VIRGINIA STATE LAW All newborns born in the State of West Virginia must be screened for hearing impairment as required in WV Code 16-22A and 16-1-7,

More information

Re: Docket No. FDA-2009-N-0294 Regulation of Tobacco Products; Request for Comments

Re: Docket No. FDA-2009-N-0294 Regulation of Tobacco Products; Request for Comments VIA Electronic Submission to http://www.regulations.gov September 29, 2009 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, rm. 1061 Rockville, MD 20852 Re: Docket

More information

TECHNICAL NOTES APPENDIX SUMMER

TECHNICAL NOTES APPENDIX SUMMER TECHNICAL NOTES APPENDIX SUMMER Hospital Performance Report Summer Update INCLUDES PENNSYLVANIA INPATIENT HOSPITAL DISCHARGES FROM JULY 1, 2006 THROUGH JUNE 30, 2007 The Pennsylvania Health Care Cost Containment

More information

HEALTHCARE REFORM. September 2012

HEALTHCARE REFORM. September 2012 HEALTHCARE REFORM Accountable Care Organizations: ACOs 101 September 2012 The enclosed slides are intended to provide you with a general overview of accountable care organizations (ACOs), created within

More information

Report to the Social Services Appropriations Subcommittee

Report to the Social Services Appropriations Subcommittee Report to the Social Services Appropriations Subcommittee Medicaid Coverage and Reimbursement for Outpatient Physical Therapy and Outpatient Occupational Therapy Prepared by the Division of Medicaid and

More information

Health Services Utilization and Medical Costs Among Medicare Atrial Fibrillation Patients / September 2010

Health Services Utilization and Medical Costs Among Medicare Atrial Fibrillation Patients / September 2010 Health Services Utilization and Medical Costs Among Medicare Atrial Fibrillation Patients / September 2010 AF Stat is sponsored by sanofi-aventis, U.S. LLC, which provided funding for this report. Avalere

More information

Potentially Preventable Hospitalizations in Pennsylvania

Potentially Preventable Hospitalizations in Pennsylvania Potentially Preventable Hospitalizations in Pennsylvania Pennsylvania Health Care Cost Containment Council June 2012 About PHC4 The Pennsylvania Health Care Cost Containment Council (PHC4) is an independent

More information

Assessing the Potential Revenue Impact to Oncology Practices under a Cancer Drug Therapy Bundled Reimbursement Model

Assessing the Potential Revenue Impact to Oncology Practices under a Cancer Drug Therapy Bundled Reimbursement Model Assessing the Potential Revenue Impact to Oncology Practices under a Cancer Drug Therapy Bundled Reimbursement Model American Society of Clinical Oncology, Inc. December 23, 2017 Prepared by: Stephen George,

More information

ACO Congress Conference Pre Session Clinical Performance Measurement

ACO Congress Conference Pre Session Clinical Performance Measurement ACO Congress Conference Pre Session Clinical Performance Measurement Lynne Rothney-Kozlak, MPH Interim VP, ACO Collaborative (Independent Consultant) October 25, 2010 Agenda for Presentation 1. The Framework

More information

Inpatient Psychiatric Facilities

Inpatient Psychiatric Facilities Payment Integrity Compass Inpatient Psychiatric Facilities Understanding IPF Calculations Updated 12/05/12 2 Questions from the Group Please use GoToMeeting to Ask a Question Use the Raise Hand function

More information

Cost-Motivated Treatment Changes in Medicare Part B:

Cost-Motivated Treatment Changes in Medicare Part B: Cost-Motivated Treatment Changes in Medicare Part B: Implications for Non- Medical Switching September 2016 THE MORAN COMPANY 1 Cost-Motivated Treatment Changes in Medicare Part B: Implications for Non-Medical

More information

The Economic Burden of Hypercholesterolaemia

The Economic Burden of Hypercholesterolaemia The Economic Burden of Hypercholesterolaemia November 2018 TABLE OF CONTENTS Acronyms 3 Executive Summary 4 Introduction 5 Approach 5 Structure of the report 5 Economic burden of hypercholesterolaemia

More information

All Part D Plan Sponsors and Medicare Hospice Providers. Part D Payment for Drugs for Beneficiaries Enrolled in Hospice Request for Comments

All Part D Plan Sponsors and Medicare Hospice Providers. Part D Payment for Drugs for Beneficiaries Enrolled in Hospice Request for Comments DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, Maryland 21244-1850 CENTER FOR MEDICARE TO: FROM: All Part D Plan Sponsors and Medicare

More information

CARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date:

CARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date: RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date: CARD/MAIL/PRE-APPROVAL/PREFERRED The Prescription Drug Coverage under this Rider [replaces] [supplements] the Prescription

More information